TRUST · 1042-TSC-3001
Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.
A Phase 3, Double-blind, Randomized, Placebo-controlled Trial of Adjunctive Ganaxolone (GNX) Treatment in Children and Adults with Tuberous Sclerosis Complex (TSC)-related Epilepsy (TrustTSC). EUDRACT: 2021-003441-38
Sponsor: MARINUS
Phase: III
Area: Epilepsy